Sharing best practice in diabetes care – Case study 6
Your T2DM patient is at the limits of using a fixed dose combination of a basal insulin and GLP-1RA. What do SA experts suggest as the next course of action?
Learning objectives
You will learn to:
- Avoid the error of overbasalisation in significantly overweight patients with type 2 diabetes and cardiovascular disease
- Maximise the value of a motivated patient’s desire to improve their lifestyle intervention with the goal of better glycaemic control
- Intervene appropriately when a patient is at the maximum dose of a fixed-ratio combination of basal insulin plus glucagon-like peptide-1 receptor agonist.
To access this module, please register or login: